ALSO READAlkem Laboratories receives EIR for its Baddi manufacturing facility Dr Reddys Laboratories announces successful USFDA inspection of its API Srikakulam Plant Unichem Laboratories receives EIR report for its formulations manufacturing facility at Ghaziabad Dr Reddy's Miryalaguda facility gets 3 USFDA observations Laurus Labs receives EIR for API facility of Unit 2
From USFDADr Reddy's Laboratories has received an Establishment Inspection Report from the USFDA following closure of audit of its API manufacturing plant at Miryalaguda. The Company was issued a form 483 with three observations subsequent to the audit of the said unit in February 2017.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)